ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,285 | +3.9% | 931,636 | +17.7% | 0.14% | +9.2% |
| Q2 2023 | $24,326 | -4.3% | 791,336 | +12.2% | 0.13% | -11.6% |
| Q1 2023 | $25,420 | +5.4% | 705,534 | +15.6% | 0.15% | -2.6% |
| Q4 2022 | $24,125 | -99.6% | 610,453 | +339.5% | 0.15% | +308.1% |
| Q3 2022 | $5,581,000 | +169.9% | 138,900 | +182.3% | 0.04% | +184.6% |
| Q2 2022 | $2,068,000 | +24.6% | 49,200 | +15.5% | 0.01% | +44.4% |
| Q1 2022 | $1,660,000 | +23.2% | 42,600 | +26.0% | 0.01% | +28.6% |
| Q4 2021 | $1,347,000 | +10.2% | 33,800 | 0.0% | 0.01% | +16.7% |
| Q3 2021 | $1,222,000 | +166.2% | 33,800 | +126.8% | 0.01% | +200.0% |
| Q2 2021 | $459,000 | +12.5% | 14,900 | +83.0% | 0.00% | 0.0% |
| Q4 2020 | $408,000 | – | 8,144 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |